Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Pharmaceuticals has completed patient accrual in its Phase 2C clinical trial of PH-10 for psoriasis.
Read more on Business Wire
Categories: Breast Cancer Information Tags: Accrual, Clinical, Completes, patient, PH10, Pharmaceuticals, Phase, Provectus, Psoriasis, Trial
Enzon to discontinue PEG-SN38 clinical program in metastatic colorectal cancer
Enzon to discontinue PEG-SN38 clinical program in metastatic colorectal cancer
Enzon Pharmaceuticals, Inc. today announced that, in light of evolving standards of care for the treatment of metastatic colorectal cancer (mCRC), the Company will discontinue its PEG-SN38 (EZN-2208) clinical program in this disease, following conclusion of its Phase II study.
Read more on News-Medical-Net
Categories: Breast Cancer Treatment Tags: cancer, Clinical, Colorectal, discontinue, Enzon, Metastatic, PEGSN38, program
AACR 2010: Adaptive design for clinical trials
Dr Donald Berry, of the MD Anderson Cancer Center, University of Texas, talks about adaptive deisgn for clinical trials. This includes identifying which patient populations benefit most, indentifying which drugs are most effective and the doses to be used in future trials. He also discusses the drugs investigated for target therapies, specifically for breast cancer treatment. Speaking from the 2010 AACR conference.
CytRx Begins Phase 1b Clinical Trial with INNO-206 in Patients with Advanced Solid Tumors
CytRx Begins Phase 1b Clinical Trial with INNO-206 in Patients with Advanced Solid Tumors
CytRx Corporation , a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Information Tags: advanced, Begins, Clinical, CytRx, INNO206, Patients, Phase, SOLiD, Trial, Tumors
The Valley Hospital and Webmedx Partner to Reduce DNFB, Improve Clinical Documentation and Automate Quality Reporting
The Valley Hospital and Webmedx Partner to Reduce DNFB, Improve Clinical Documentation and Automate Quality Reporting
Webmedx, a leading medical content provider and the third largest medical transcription service in the U.S., today announced that The Valley Hospital, a 451-bed acute care facility and member of Valley Health System in Ridgewood, New Jersey, has begun an enterprise-wide implementation of Webmedx’s newest solution for clinical documentation improvement and quality reporting, QualityAnalyticsâ¢.
Read more on PR Newswire via Yahoo! Finance